--- Company communicates progress on numerous indicators of economic, environmental, and social performance
INDIANAPOLIS, Dec. 5, 2013 /PRNewswire/ -- Eli Lilly and Company has released its 2012-13 Corporate Responsibility Report [http://www.lilly.com/Documents/Lilly_201...]. The report offers a comprehensive look at the company's progress on numerous corporate responsibility goals and efforts, including:
--- Charitable contributions
-- Lilly's global health programs [http://www.lillyglobalhealth.com/]
focused on tuberculosis and diabetes
-- Philanthropic programs, such as Lilly's annual Global Day of Service
[http://www.lillygdos.com/]
-- Scientific initiatives, such as increasing minority representation in
clinical trials
[http://www.lilly.com/about/diversity/marketplace/clinical-tr...
clinical-trials.aspx].
"Lilly's greatest contribution to society is continuing to discover and develop innovative medicines that help make life better," said John C. Lechleiter, Ph.D., Lilly chairman, president, and chief executive officer. "Being a trustworthy global citizen also requires us to conduct our business ethically, responsibly, and transparently--and to strategically use our resources, knowledge, and capabilities to help improve global health and bring value to patients, society, and shareholders."
Among the report's highlights:
--- Committed to provide $30 million to fight the rising burden of
non-communicable diseases (NCDs) in developing nations from 2012-2016
through the Lilly NCD Partnership
[http://www.lillyglobalhealth.com/ncd/ncd...]
-- Pledged an additional $30 million to fund the Lilly MDR-TB Partnership
[http://www.lillyglobalhealth.com/mdr-tb/mdr-tb.html] through 2016,
focusing on healthcare provider training and improving the supply of and
access to safe, effective, and high-quality medications
-- Helped over 300,000 people gain access to our medicines through the U.S.
patient-assistance program, Lilly TruAssist
[http://www.lillytruassist.com/Pages/inde...], an increase of 18
percent over 2011
-- Since 2011, nearly 600 employees have devoted nearly 24,000 hours to
Connecting Hearts Abroad
[http://www.lilly.com/Responsibility/comm...
-abroad.aspx], a program that allows employees to volunteer on company
time in countries where people lack basic resources or access to quality
health care
-- Donated more than $12 million to the United Way in 2012, a record high
for Lilly
-- Added more than 360 new clinical trial sites with minority patient
populations of more than 25 percent
-- Received a perfect score of 100 on the Human Rights Campaign's "Best
Places to Work: Corporate Index" in 2012
-- Recognized by DiversityInc as one of the "Top 50 Companies for
Diversity," and as a model of workplace flexibility for employees
-- Selected as a 2020 Women on Boards Winning Company for commitment to
diversity on the board of directors
-- Decreased water intake by nearly 37 percent compared to 2007
-- Decreased greenhouse gas emissions by nearly 17 percent between 2007 and
2012.
The Lilly 2012-13 Corporate Responsibility Report also serves as Lilly's annual Communication on Progress to the United Nations Global Compact (UNGC). As a signatory of the UNGC, Lilly shares its progress annually on 10 universally accepted principles related to human rights, labor, the environment, and anti-corruption.
This year's report [http://www.lilly.com/Documents/Lilly_201...] is available on Lilly.com [http://www.lilly.com/Pages/Home.aspx].
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com [http://www.lilly.com/]. CR-LLY
Refer to: +1-317-489-7109 - David Marbaugh
(Logo: http://photos.prnewswire.com/prnh/200312... [http://photos.prnewswire.com/prnh/200312...] )
Web site: http://www.lilly.com/
